1
|
Hacker RM, Grimard DM, Morgan KA, Saleh E, Wrublik MM, Meiss CJ, Kant CC, Jones MA, Brennessel WW, Webb MI. Ru(II)-arene azole complexes as anti-amyloid-β agents. Dalton Trans 2024. [PMID: 39093049 DOI: 10.1039/d4dt01740d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/04/2024]
Abstract
With the recent clinical success of anti-amyloid-β (Aβ) monoclonal antibodies, there is a renewed interest in agents which target the Aβ peptide of Alzheimer's disease (AD). Metal complexes are particularly well-suited for this development, given their structural versatility and ability to form stabile interactions with soluble Aβ. In this report, a small series of ruthenium-arene complexes were evaluated for their respective ability to modulate both the aggregation and cytotoxicity of Aβ. First, the stability of the complexes was evaluated in a variety of aqueous media where the complexes demonstrated exceptional stability. Next, the ability to coordinate and modulate the Aβ peptide was evaluated using several spectroscopic methods, including thioflavin T (ThT) fluorescence, dynamic light scattering (DLS), and transmission electron microscopy (TEM). Overall, the complex RuBO consistently gave the greatest inhibitory action towards Aβ aggregation, which correlated with its ability to coordinate to Aβ in solution. Furthermore, RuBO also had the lowest affinity for serum albumin, which is a key consideration for a neurotherapeutic, as this protein does not cross the blood brain barrier. Lastly, RuBO also displayed promising neuroprotective properties, as it had the greatest inhibition of Aβ-inducted cytotoxicity.
Collapse
Affiliation(s)
- Ryan M Hacker
- Department of Chemistry and Biochemistry, SUNY Geneseo, Geneseo, NY, 14454, USA.
| | - Daniela M Grimard
- Department of Chemistry and Biochemistry, SUNY Geneseo, Geneseo, NY, 14454, USA.
| | - Katie A Morgan
- Department of Chemistry and Biochemistry, SUNY Geneseo, Geneseo, NY, 14454, USA.
| | - Eaman Saleh
- Department of Chemistry, Illinois State University, Normal, IL, 61790, USA
| | - Morgan M Wrublik
- Department of Chemistry, Illinois State University, Normal, IL, 61790, USA
| | - Cade J Meiss
- Department of Chemistry, Illinois State University, Normal, IL, 61790, USA
| | - Caitlyn C Kant
- Department of Chemistry, Illinois State University, Normal, IL, 61790, USA
| | - Marjorie A Jones
- Department of Chemistry, Illinois State University, Normal, IL, 61790, USA
| | | | - Michael I Webb
- Department of Chemistry and Biochemistry, SUNY Geneseo, Geneseo, NY, 14454, USA.
| |
Collapse
|
2
|
García-García A, Rojas S, Rodríguez-Diéguez A. Therapy and diagnosis of Alzheimer's disease: from discrete metal complexes to metal-organic frameworks. J Mater Chem B 2023; 11:7024-7040. [PMID: 37435638 DOI: 10.1039/d3tb00427a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/13/2023]
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder affecting 44 million people worldwide. Although many issues (pathogenesis, genetics, clinical features, and pathological aspects) are still unknown, this disease is characterized by noticeable hallmarks such as the formation of β-amyloid plaques, hyperphosphorylation of tau proteins, the overproduction of reactive oxygen species, and the reduction of acetylcholine levels. There is still no cure for AD and the current treatments are aimed at regulating the cholinesterase levels, attenuating symptoms temporarily rather than preventing the AD progression. In this context, coordination compounds are regarded as a promissing tool in AD treatment and/or diagnosis. Coordination compounds (discrete or polymeric) possess several features that make them an interesting option for developing new drugs for AD (good biocompatibility, porosity, synergetic effects of ligand-metal, fluorescence, particle size, homogeneity, monodispersity, etc.). This review discusses the recent progress in the development of novel discrete metal complexes and metal-organic frameworks (MOFs) for the treatment, diagnosis and theragnosis of AD. These advanced therapies for AD treatment are organized according to the target: Aβ peptides, hyperphosphorylated tau proteins, synaptic dysfunction, and mitochondrial failure with subsequent oxidative stress.
Collapse
Affiliation(s)
- Amalia García-García
- Department of Inorganic Chemistry, Faculty of Science, University of Granada, Av. Fuentenueva S/N, 18071 Granada, Spain.
- Centro de Química del Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, 18 sur & Av. San Claudio, Col. San Manuel, 72570 Puebla, Mexico
| | - Sara Rojas
- Department of Inorganic Chemistry, Faculty of Science, University of Granada, Av. Fuentenueva S/N, 18071 Granada, Spain.
| | - Antonio Rodríguez-Diéguez
- Department of Inorganic Chemistry, Faculty of Science, University of Granada, Av. Fuentenueva S/N, 18071 Granada, Spain.
| |
Collapse
|
3
|
Yawson GK, Will MF, Huffman SE, Strandquist ET, Bothwell PJ, Oliver EB, Apuzzo CF, Platt DC, Weitzel CS, Jones MA, Ferrence GM, Hamaker CG, Webb MI. A Dual-Pronged Approach: A Ruthenium(III) Complex That Modulates Amyloid-β Aggregation and Disrupts Its Formed Aggregates. Inorg Chem 2022; 61:2733-2744. [PMID: 35102739 DOI: 10.1021/acs.inorgchem.1c01651] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Alzheimer's disease (AD) is a devastating neurological disorder for which soluble oligomers of the peptide amyloid-β (Aβ) are now recognized as the neurotoxic species. Metal-based therapeutics are uniquely suited to target Aβ, with ruthenium-based (Ru) complexes emerging as propitious candidates. Recently, azole-based Ru(III) complexes were observed to modulate the aggregation of Aβ in solution, where the inclusion of a primary amine proximal to the ligand coordination site improved the activity of the complexes. To advance these structure-activity relationships, a series of oxazole-based Ru complexes were prepared and evaluated for their ability to modulate Aβ aggregation. From these studies, a lead candidate, Oc, emerged that had superior activity relative to its azole predecessors in modulating the aggregation of soluble Aβ and diminishing its cytotoxicity. Further evaluation of Oc demonstrated its ability to disrupt formed Aβ aggregates, resulting in smaller amorphous species. Because altering both sides of the aggregation equilibrium for Aβ has not been previously suggested for metal-based complexes for AD, this work represents an exciting new avenue for improved therapeutic success.
Collapse
Affiliation(s)
- Gideon K Yawson
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Mark F Will
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Samantha E Huffman
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Evan T Strandquist
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Paige J Bothwell
- Core Microscope Facility, Department of Biological Sciences, Northern Illinois University, DeKalb, Illinois 60115, United States
| | - Ethan B Oliver
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - C Fiore Apuzzo
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - David C Platt
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Christopher S Weitzel
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Marjorie A Jones
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Gregory M Ferrence
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Christopher G Hamaker
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Michael I Webb
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| |
Collapse
|
4
|
Wall BJ, Will MF, Yawson GK, Bothwell PJ, Platt DC, Apuzzo CF, Jones MA, Ferrence GM, Webb MI. Importance of Hydrogen Bonding: Structure-Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer's Disease Therapy. J Med Chem 2021; 64:10124-10138. [PMID: 34197109 DOI: 10.1021/acs.jmedchem.1c00360] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Alzheimer's disease (AD) is the most common form of dementia, where one of the pathological hallmarks of AD is extracellular protein deposits, the primary component of which is the peptide amyloid-β (Aβ). Recently, the soluble form of Aβ has been recognized as the primary neurotoxic species, making it an important target for therapeutic development. Metal-based drugs are promising candidates to target Aβ, as the interactions with the peptide can be tuned by ligand design. In the current study, 11 ruthenium complexes containing pyridine-based ligands were prepared, where the functional groups at the para position on the coordinated pyridine ligand were varied to determine structure-activity relationships. Overall, the complexes with terminal primary amines had the greatest impact on modulating the aggregation of Aβ and diminishing its cytotoxicity. These results identify the importance of specific intermolecular interactions and are critical in the advancement of metal-based drugs for AD therapy.
Collapse
Affiliation(s)
- Brendan J Wall
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Mark F Will
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Gideon K Yawson
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Paige J Bothwell
- Core Microscope Facility, Department of Biological Sciences, Northern Illinois University, DeKalb, Illinois 60115, United States
| | - David C Platt
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - C Fiore Apuzzo
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Marjorie A Jones
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Gregory M Ferrence
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| | - Michael I Webb
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States
| |
Collapse
|
5
|
Bataglioli JC, Gomes LMF, Maunoir C, Smith JR, Cole HD, McCain J, Sainuddin T, Cameron CG, McFarland SA, Storr T. Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru(ii) polypyridyl complexes. Chem Sci 2021; 12:7510-7520. [PMID: 34163842 PMCID: PMC8171320 DOI: 10.1039/d1sc00004g] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2021] [Accepted: 04/19/2021] [Indexed: 01/01/2023] Open
Abstract
Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates are considered central to disease progression. Thus, the development of small molecules capable of modulating Aβ peptide aggregation may provide critical insight into the pathophysiology of AD. In this work we investigate how photoactivation of three distorted Ru(ii) polypyridyl complexes (Ru1-3) alters the aggregation profile of the Aβ peptide. Photoactivation of Ru1-3 results in the loss of a 6,6'-dimethyl-2,2'-bipyridyl (6,6'-dmb) ligand, affording cis-exchangeable coordination sites for binding to the Aβ peptide. Both Ru1 and Ru2 contain an extended planar imidazo[4,5-f][1,10]phenanthroline ligand, as compared to a 2,2'-bipyridine ligand for Ru3, and we show that the presence of the phenanthroline ligand promotes covalent binding to Aβ peptide His residues, and in addition, leads to a pronounced effect on peptide aggregation immediately after photoactivation. Interestingly, all three complexes resulted in a similar aggregate size distribution at 24 h, forming insoluble amorphous aggregates as compared to significant fibril formation for peptide alone. Photoactivation of Ru1-3 in the presence of pre-formed Aβ1-42 fibrils results in a change to amorphous aggregate morphology, with Ru1 and Ru2 forming large amorphous aggregates immediately after activation. Our results show that photoactivation of Ru1-3 in the presence of either monomeric or fibrillar Aβ1-42 results in the formation of large amorphous aggregates as a common endpoint, with Ru complexes incorporating the extended phenanthroline ligand accelerating this process and thereby limiting the formation of oligomeric species in the initial stages of the aggregation process that are reported to show considerable toxicity.
Collapse
Affiliation(s)
| | - Luiza M F Gomes
- Department of Chemistry, Simon Fraser University BC Canada V5A-1S6
| | - Camille Maunoir
- Department of Chemistry, Simon Fraser University BC Canada V5A-1S6
| | - Jason R Smith
- Department of Chemistry, Simon Fraser University BC Canada V5A-1S6
| | - Houston D Cole
- Department of Chemistry and Biochemistry, University of Texas Arlington Texas USA 76019
| | - Julia McCain
- Department of Chemistry, Acadia University Wolfville Nova Scotia Canada B4P 2R6
| | - Tariq Sainuddin
- Department of Chemistry, Acadia University Wolfville Nova Scotia Canada B4P 2R6
| | - Colin G Cameron
- Department of Chemistry and Biochemistry, University of Texas Arlington Texas USA 76019
| | - Sherri A McFarland
- Department of Chemistry and Biochemistry, University of Texas Arlington Texas USA 76019
| | - Tim Storr
- Department of Chemistry, Simon Fraser University BC Canada V5A-1S6
| |
Collapse
|
6
|
Manna SL, Florio D, Iacobucci I, Napolitano F, Benedictis ID, Malfitano AM, Monti M, Ravera M, Gabano E, Marasco D. A Comparative Study of the Effects of Platinum (II) Complexes on β-Amyloid Aggregation: Potential Neurodrug Applications. Int J Mol Sci 2021; 22:ijms22063015. [PMID: 33809522 PMCID: PMC7998721 DOI: 10.3390/ijms22063015] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2021] [Revised: 03/09/2021] [Accepted: 03/10/2021] [Indexed: 01/21/2023] Open
Abstract
Herein the effects of three platinum complexes, namely (SP-4-2)-(2,2'-bipyridine)dichloridoplatinum(II), Pt-bpy, (SP-4-2)-dichlorido(1,10-phenanthroline) platinum(II), Pt-phen, and (SP-4-2)-chlorido(2,2':6',2''-terpyridine)platinum(II) chloride, Pt-terpy, on the aggregation of an amyloid model system derived from the C-terminal domain of Aβ peptide (Aβ21-40) were investigated. Thioflavin T (ThT) binding assays revealed the ability of Pt(II) compounds to repress amyloid aggregation in a dose-dependent way, whereas the ability of Aβ21-40 peptide to interfere with ligand field of metal complexes was analyzed through UV-Vis absorption spectroscopy and electrospray ionization mass spectrometry. Spectroscopic data provided micromolar EC50 values and allowed to assess that the observed inhibition of amyloid aggregation is due to the formation of adducts between Aβ21-40 peptide and complexes upon the release of labile ligands as chloride and that they can explore different modes of coordination toward Aβ21-40 with respect to the entire Aβ1-40 polypeptide. In addition, conformational studies through circular dichroism (CD) spectroscopy suggested that Pt-terpy induces soluble β-structures of monomeric Aβ21-40, thus limiting self-recognition. Noticeably, Pt-terpy demonstrated the ability to reduce the cytotoxicity of amyloid peptide in human SH-SY5Y neuroblastoma cells. Presented data corroborate the hypothesis to enlarge the application field of already known metal-based agents to neurodegenerative diseases, as potential neurodrugs.
Collapse
Affiliation(s)
- Sara La Manna
- Department of Pharmacy, University of Naples “Federico II”, 80131 Naples, Italy; (S.L.M.); (D.F.); (I.D.B.)
| | - Daniele Florio
- Department of Pharmacy, University of Naples “Federico II”, 80131 Naples, Italy; (S.L.M.); (D.F.); (I.D.B.)
| | - Ilaria Iacobucci
- Department of Chemical Sciences, CEINGE Biotecnologie Avanzate S.c.a r.l., “University of Naples Federico II”, 80131 Naples, Italy; (I.I.); (M.M.)
| | - Fabiana Napolitano
- Department of Translational Medical Science, University of Naples “Federico II”, 80131 Naples, Italy; (F.N.); (A.M.M.)
| | - Ilaria De Benedictis
- Department of Pharmacy, University of Naples “Federico II”, 80131 Naples, Italy; (S.L.M.); (D.F.); (I.D.B.)
| | - Anna Maria Malfitano
- Department of Translational Medical Science, University of Naples “Federico II”, 80131 Naples, Italy; (F.N.); (A.M.M.)
| | - Maria Monti
- Department of Chemical Sciences, CEINGE Biotecnologie Avanzate S.c.a r.l., “University of Naples Federico II”, 80131 Naples, Italy; (I.I.); (M.M.)
| | - Mauro Ravera
- Department of Sciences and Technological Innovation (DiSIT), University of Piemonte Orientale “A. Avogadro”, 15121 Alessandria, Italy; (M.R.); (E.G.)
| | - Elisabetta Gabano
- Department of Sciences and Technological Innovation (DiSIT), University of Piemonte Orientale “A. Avogadro”, 15121 Alessandria, Italy; (M.R.); (E.G.)
| | - Daniela Marasco
- Department of Pharmacy, University of Naples “Federico II”, 80131 Naples, Italy; (S.L.M.); (D.F.); (I.D.B.)
- Correspondence: ; Tel.: +39-081-2534512; Fax: +39-081-2534574
| |
Collapse
|
7
|
Liu C, Luo X. Potential molecular and graphene oxide chelators to dissolve amyloid-β plaques in Alzheimer's disease: a density functional theory study. J Mater Chem B 2021; 9:2736-2746. [PMID: 33688880 DOI: 10.1039/d0tb02985h] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
The onset of Alzheimer's disease (AD) is caused by amyloid-β (Aβ) aggregation. Elevated levels of metals, specifically copper, zinc, iron, and aluminum, accumulate in senile Aβ; plaque deposits, disrupting normal brain homeostasis and cognitive functions. In this investigation, we studied the potential of several molecular and graphene oxide chelators to be used for future AD research and chelation therapy. To understand the interactions between selected metals (Cu, Zn, Fe, and Al), the Aβ peptide, and various potential metal chelating compounds, we implemented the density functional theory (DFT) method to calculate the binding energies of each metal-molecule complex. The binding energy of each metal-chelator complex was compared with that of the metal-Aβ compound to determine the chelation potential of the selected chelator. The potential chelating agents studied were 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone (INNHQ), 8-hydroxyquinoline-2-carboxaldehyde 2-furoyl hydrazone (HQFUH), quercetin, and graphene oxide (GO). Our calculated binding energies revealed that the HQFUH molecule holds direct ability to chelate copper, zinc, iron, and aluminum. In addition, the GO complex with a 12.5% oxygen concentration demonstrates aluminum chelation ability. Our results demonstrate that HQFUH and GO can be used in future AD drug development research and therapy to target toxic metal-Aβ interactions and reduce Aβ aggregation.
Collapse
Affiliation(s)
- Christina Liu
- National Graphene Research and Development Center, Springfield, Virginia 22151, USA.
| | | |
Collapse
|
8
|
Yawson GK, Huffman SE, Fisher SS, Bothwell PJ, Platt DC, Jones MA, Ferrence GM, Hamaker CG, Webb MI. Ruthenium(III) complexes with imidazole ligands that modulate the aggregation of the amyloid-β peptide via hydrophobic interactions. J Inorg Biochem 2020; 214:111303. [PMID: 33166864 DOI: 10.1016/j.jinorgbio.2020.111303] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Revised: 10/27/2020] [Accepted: 10/27/2020] [Indexed: 12/14/2022]
Abstract
Alzheimer's disease (AD) is the most common form of dementia, characterized by extracellular protein deposits, comprised primarily of the peptide amyloid-beta (Aβ), are a pathological indicator of the disease. Commonly known as Aβ plaques, these deposits contain a relatively high concentration of metals, making metallotherapeutics uniquely suited to target soluble Aβ, thereby limiting its aggregation and cytotoxicity. Ruthenium-based complexes are promising candidates for advancement, as the complex PMRU20 (2-aminothiazolium [trans-RuCl4(2-aminothiazole)2]) and several thiazole-based derivatives were found to prevent the aggregation of Aβ, with hydrogen-bonding functional groups improving their performance. Further investigation into the impact of the heteroatom in the azole ring on the activity of Ru complexes was achieved through the synthesis and evaluation of a small set of imidazole-based compounds. The ability of the complexes to prevent the aggregation of Aβ was determined where the same sample was subjected to analysis by three complementary methods: ThT fluorescence, dynamic light scattering (DLS), and transmission electron microscopy (TEM). It was found that hydrophobic interactions, along with hydrogen-bonding via the imidazole nitrogen heteroatom, promoted interactions with the Aβ peptide, thereby limiting its aggregation. Furthermore, it was found that having rapid and sequential exchange proved detrimental as it resulted in a decreased association with Aβ. These results highlight important considerations between a balance of intermolecular interactions and ligand exchange kinetics in the design of further therapeutic candidates.
Collapse
Affiliation(s)
- Gideon K Yawson
- Department of Chemistry, Illinois State University, Normal, IL 61790-4160, United States of America
| | - Samantha E Huffman
- Department of Chemistry, Illinois State University, Normal, IL 61790-4160, United States of America
| | - Samuel S Fisher
- Department of Chemistry, Illinois State University, Normal, IL 61790-4160, United States of America
| | - Paige J Bothwell
- Core Microscope Facility, Department of Biological Sciences, Northern Illinois University, DeKalb, IL 60115, United States of America
| | - David C Platt
- Department of Chemistry, Illinois State University, Normal, IL 61790-4160, United States of America
| | - Marjorie A Jones
- Department of Chemistry, Illinois State University, Normal, IL 61790-4160, United States of America
| | - Gregory M Ferrence
- Department of Chemistry, Illinois State University, Normal, IL 61790-4160, United States of America
| | - Christopher G Hamaker
- Department of Chemistry, Illinois State University, Normal, IL 61790-4160, United States of America
| | - Michael I Webb
- Department of Chemistry, Illinois State University, Normal, IL 61790-4160, United States of America.
| |
Collapse
|
9
|
Metal complexes that bind to the amyloid-β peptide of relevance to Alzheimer’s disease. Coord Chem Rev 2020. [DOI: 10.1016/j.ccr.2020.213255
expr 886172045 + 931245952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023]
|
10
|
Gomes LM, Bataglioli JC, Storr T. Metal complexes that bind to the amyloid-β peptide of relevance to Alzheimer’s disease. Coord Chem Rev 2020. [DOI: 10.1016/j.ccr.2020.213255] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
11
|
Huffman SE, Yawson GK, Fisher SS, Bothwell PJ, Platt DC, Jones MA, Hamaker CG, Webb MI. Ruthenium(iii) complexes containing thiazole-based ligands that modulate amyloid-β aggregation. Metallomics 2020; 12:491-503. [PMID: 32239079 DOI: 10.1039/d0mt00054j] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Alzheimer's Disease (AD) is a devastating neurodegenerative disorder where one of the commonly observed pathological hallmarks is extracellular deposits of the peptide amyloid-β (Aβ). These deposits contain a high concentration of metals and initially presented a promising target for therapy; however it has become increasingly evident that the soluble form of the peptide is neurotoxic, not the amyloidogenic species. Metal-based therapeutics are uniquely suited to target soluble Aβ and have shown considerable promise to prevent the aggregation and induced cytotoxicity of the peptide in vitro. Herein, we have prepared a small series of derivatives of two promising Ru(iii) complexes NAMI-A (imidazolium [trans-RuCl4(1H-imidazole)(dimethyl sulfoxide-S)]) and PMRU20 (2-aminothiazolium [trans-RuCl4(2-aminothiazole)2]), to determine structure-activity relationships (SAR) for Ru(iii) therapeutics for AD. Using the three complementary methods of Thioflavin T fluorescence, dynamic light scattering (DLS), and transmission electron microscopy (TEM), it was determined that the symmetry around the metal center did not significantly impact the activity of the complexes, but rather the attached thiazole ligand(s) mitigated Aβ aggregation. Across both families of Ru(iii) complexes the determined SAR for the functional groups on the thiazole ligands to modulate Aβ aggregation were NH2 > CH3 > H. These results highlight the importance of secondary interactions between the metallotherapeutic and the Aβ peptide where hydrogen-bonding has the greatest impact on modulating Aβ aggregation.
Collapse
Affiliation(s)
- Samantha E Huffman
- Department of Chemistry, Illinois State University, Normal, IL, 61790-4160, USA.
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Gomes LMF, Bataglioli JC, Jussila AJ, Smith JR, Walsby CJ, Storr T. Modification of Aβ Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes. Front Chem 2019; 7:838. [PMID: 31921764 PMCID: PMC6915085 DOI: 10.3389/fchem.2019.00838] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Accepted: 11/18/2019] [Indexed: 12/31/2022] Open
Abstract
Alzheimer's disease (AD) is the most common form of dementia, leading to loss of cognition, and eventually death. The disease is characterized by the formation of extracellular aggregates of the amyloid-beta (Aβ) peptide and neurofibrillary tangles of tau protein inside cells, and oxidative stress. In this study, we investigate a series of Ru(III) complexes (Ru-N) derived from NAMI-A in which the imidazole ligand has been substituted for pyridine derivatives, as potential therapeutics for AD. The ability of the Ru-N series to bind to Aβ was evaluated by NMR and ESI-MS, and their influence on the Aβ peptide aggregation process was investigated via electrophoresis gel/western blot, TEM, turbidity, and Bradford assays. The complexes were shown to bind covalently to the Aβ peptide, likely via a His residue. Upon binding, the complexes promote the formation of soluble high molecular weight aggregates, in comparison to peptide precipitation for peptide alone. In addition, TEM analysis supports both amorphous and fibrillar aggregate morphology for Ru-N treatments, while only large amorphous aggregates are observed for peptide alone. Overall, our results show that the Ru-N complexes modulate Aβ peptide aggregation, however, the change in the size of the pyridine ligand does not substantially alter the Aβ aggregation process.
Collapse
Affiliation(s)
- Luiza M F Gomes
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
| | | | - Allison J Jussila
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
| | - Jason R Smith
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
| | - Charles J Walsby
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
| | - Tim Storr
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
| |
Collapse
|
13
|
Structural and biological evaluation of a platinum complex as a potential anti-neurodegenerative agent. Inorganica Chim Acta 2019. [DOI: 10.1016/j.ica.2019.03.027] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
14
|
Strodel B, Coskuner-Weber O. Transition Metal Ion Interactions with Disordered Amyloid-β Peptides in the Pathogenesis of Alzheimer's Disease: Insights from Computational Chemistry Studies. J Chem Inf Model 2019; 59:1782-1805. [PMID: 30933519 DOI: 10.1021/acs.jcim.8b00983] [Citation(s) in RCA: 40] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Monomers and oligomers of the amyloid-β peptide aggregate to form the fibrils found in the brains of Alzheimer's disease patients. These monomers and oligomers are largely disordered and can interact with transition metal ions, affecting the mechanism and kinetics of amyloid-β aggregation. Due to the disordered nature of amyloid-β, its rapid aggregation, as well as solvent and paramagnetic effects, experimental studies face challenges in the characterization of transition metal ions bound to amyloid-β monomers and oligomers. The details of the coordination chemistry between transition metals and amyloid-β obtained from experiments remain debated. Furthermore, the impact of transition metal ion binding on the monomeric or oligomeric amyloid-β structures and dynamics are still poorly understood. Computational chemistry studies can serve as an important complement to experimental studies and can provide additional knowledge on the binding between amyloid-β and transition metal ions. Many research groups conducted first-principles calculations, ab initio molecular dynamics simulations, quantum mechanics/classical mechanics simulations, and classical molecular dynamics simulations for studying the interplay between transition metal ions and amyloid-β monomers and oligomers. This review summarizes the current understanding of transition metal interactions with amyloid-β obtained from computational chemistry studies. We also emphasize the current view of the coordination chemistry between transition metal ions and amyloid-β. This information represents an important foundation for future metal ion chelator and drug design studies aiming to combat Alzheimer's disease.
Collapse
Affiliation(s)
- Birgit Strodel
- Institute of Complex Systems: Structural Biochemistry (ICS-6) , Forschungszentrum Jülich GmbH , Jülich 52425 , Germany.,Institute of Theoretical and Computational Chemistry , Heinrich Heine University Düsseldorf , Universitätstrasse 1 , Düsseldorf 40225 , Germany
| | - Orkid Coskuner-Weber
- Molecular Biotechnology , Turkish-German University , Sahinkaya Caddesi, No. 86, Beykoz , Istanbul 34820 , Turkey
| |
Collapse
|
15
|
Sales TA, Prandi IG, Castro AAD, Leal DHS, Cunha EFFD, Kuca K, Ramalho TC. Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments. Int J Mol Sci 2019; 20:E1829. [PMID: 31013856 PMCID: PMC6514778 DOI: 10.3390/ijms20081829] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2019] [Revised: 04/07/2019] [Accepted: 04/09/2019] [Indexed: 02/07/2023] Open
Abstract
The brain has a unique biological complexity and is responsible for important functions in the human body, such as the command of cognitive and motor functions. Disruptive disorders that affect this organ, e.g. neurodegenerative diseases (NDDs), can lead to permanent damage, impairing the patients' quality of life and even causing death. In spite of their clinical diversity, these NDDs share common characteristics, such as the accumulation of specific proteins in the cells, the compromise of the metal ion homeostasis in the brain, among others. Despite considerable advances in understanding the mechanisms of these diseases and advances in the development of treatments, these disorders remain uncured. Considering the diversity of mechanisms that act in NDDs, a wide range of compounds have been developed to act by different means. Thus, promising compounds with contrasting properties, such as chelating agents and metal-based drugs have been proposed to act on different molecular targets as well as to contribute to the same goal, which is the treatment of NDDs. This review seeks to discuss the different roles and recent developments of metal-based drugs, such as metal complexes and metal chelating agents as a proposal for the treatment of NDDs.
Collapse
Affiliation(s)
- Thais A Sales
- Laboratory of Molecular Modeling, Department of Chemistry, Federal University of Lavras, Lavras/MG, 37200-000, Brazil.
| | - Ingrid G Prandi
- Laboratory of Molecular Modeling, Department of Chemistry, Federal University of Lavras, Lavras/MG, 37200-000, Brazil.
| | - Alexandre A de Castro
- Laboratory of Molecular Modeling, Department of Chemistry, Federal University of Lavras, Lavras/MG, 37200-000, Brazil.
| | - Daniel H S Leal
- Department of Health Sciences, Federal University of Espírito Santo, São Mateus/ES, 29932-540, Brazil.
| | - Elaine F F da Cunha
- Laboratory of Molecular Modeling, Department of Chemistry, Federal University of Lavras, Lavras/MG, 37200-000, Brazil.
| | - Kamil Kuca
- Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, 500 03, Czech Republic..
- Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, 500 03 Czech Republic.
| | - Teodorico C Ramalho
- Laboratory of Molecular Modeling, Department of Chemistry, Federal University of Lavras, Lavras/MG, 37200-000, Brazil.
- Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, 500 03, Czech Republic..
| |
Collapse
|
16
|
Gomes LMF, Mahammed A, Prosser KE, Smith JR, Silverman MA, Walsby CJ, Gross Z, Storr T. A catalytic antioxidant for limiting amyloid-beta peptide aggregation and reactive oxygen species generation. Chem Sci 2019; 10:1634-1643. [PMID: 30842826 PMCID: PMC6369440 DOI: 10.1039/c8sc04660c] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2018] [Accepted: 11/27/2018] [Indexed: 12/29/2022] Open
Abstract
Alzheimer's disease (AD) is a multifaceted disease that is characterized by increased oxidative stress, metal-ion dysregulation, and the formation of intracellular neurofibrillary tangles and extracellular amyloid-β (Aβ) aggregates. In this work we report the large affinity binding of the iron(iii) 2,17-bis-sulfonato-5,10,15-tris(pentafluorophenyl)corrole complex FeL1 to the Aβ peptide (K d ∼ 10-7) and the ability of the bound FeL1 to act as a catalytic antioxidant in both the presence and absence of Cu(ii) ions. Specific findings are that: (a) an Aβ histidine residue binds axially to FeL1; (b) that the resulting adduct is an efficient catalase; (c) this interaction restricts the formation of high molecular weight peptide aggregates. UV-Vis and electron paramagnetic resonance (EPR) studies show that although the binding of FeL1 does not influence the Aβ-Cu(ii) interaction (K d ∼ 10-10), bound FeL1 still acts as an antioxidant thereby significantly limiting reactive oxygen species (ROS) generation from Aβ-Cu. Overall, FeL1 is shown to bind to the Aβ peptide, and modulate peptide aggregation. In addition, FeL1 forms a ternary species with Aβ-Cu(ii) and impedes ROS generation, thus showing the promise of discrete metal complexes to limit the toxicity pathways of the Aβ peptide.
Collapse
Affiliation(s)
- Luiza M F Gomes
- Department of Chemistry , Simon Fraser University , V5A-1S6 , Burnaby , BC , Canada .
| | - Atif Mahammed
- Schulich Faculty of Chemistry , Technion-Israel Institute of Technology , Haifa , 32000 , Israel .
| | - Kathleen E Prosser
- Department of Chemistry , Simon Fraser University , V5A-1S6 , Burnaby , BC , Canada .
| | - Jason R Smith
- Department of Chemistry , Simon Fraser University , V5A-1S6 , Burnaby , BC , Canada .
| | - Michael A Silverman
- Department of Biological Sciences , Simon Fraser University , V5A-1S6 , Burnaby , BC , Canada
| | - Charles J Walsby
- Department of Chemistry , Simon Fraser University , V5A-1S6 , Burnaby , BC , Canada .
| | - Zeev Gross
- Schulich Faculty of Chemistry , Technion-Israel Institute of Technology , Haifa , 32000 , Israel .
| | - Tim Storr
- Department of Chemistry , Simon Fraser University , V5A-1S6 , Burnaby , BC , Canada .
| |
Collapse
|
17
|
Turner M, Mutter ST, Kennedy-Britten OD, Platts JA. Replica exchange molecular dynamics simulation of the coordination of Pt( ii)-Phenanthroline to amyloid-β. RSC Adv 2019; 9:35089-35097. [PMID: 35530686 PMCID: PMC9074135 DOI: 10.1039/c9ra04637b] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2019] [Accepted: 10/24/2019] [Indexed: 12/30/2022] Open
Abstract
We report replica exchange molecular dynamics (REMD) simulations of the complex formed between amyloid-β peptides and platinum bound to a phenanthroline ligand, Pt(phen). After construction of an AMBER-style forcefield for the Pt complex, REMD simulation employing temperatures between 270 and 615 K was used to provide thorough sampling of the conformational freedom available to the peptide. We find that the full length peptide Aβ42, in particular, frequently adopts a compact conformation with a large proportion of α- and 3,10-helix content, with smaller amounts of β-strand in the C-terminal region of the peptide. Helical structures are more prevalent than in the metal-free peptide, while turn and strand conformations are markedly less common. Non-covalent interactions, including salt-bridges, hydrogen bonds, and π-stacking between aromatic residues and the phenanthroline ligand, are common, and markedly different from those seen in the amyloid-β peptides alone. Replica exchange molecular dynamics are used to explore the conformational freedom of amyloid-βbound to Pt(phenanthroline), highlighting important differences in secondary and tertiary structure from the metal-free peptide.![]()
Collapse
|
18
|
Mutter ST, Turner M, Deeth RJ, Platts JA. Metal Binding to Amyloid-β 1-42: A Ligand Field Molecular Dynamics Study. ACS Chem Neurosci 2018; 9:2795-2806. [PMID: 29898363 DOI: 10.1021/acschemneuro.8b00210] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Ligand field molecular mechanics simulation has been used to model the interactions of copper(II) and platinum(II) with the amyloid-β1-42 peptide monomer. Molecular dynamics over several microseconds for both metalated systems are compared to analogous results for the free peptide. Significant differences in structural parameters are observed, both between Cu and Pt bound systems as well as between free and metal-bound peptide. Both metals stabilize the formation of helices in the peptide as well as reducing the content of β secondary structural elements compared to the unbound monomer. This is in agreement with experimental reports of metals reducing β-sheet structures, leading to formation of amorphous aggregates over amyloid fibrils. The shape and size of the peptide structures also undergo noteworthy change, with the free peptide exhibiting globular-like structure, platinum(II) system adopting extended structures, and copper(II) system resulting in a mixture of conformations similar to both of these. Salt bridge networks exhibit major differences: the Asp23-Lys28 salt bridge, known to be important in fibril formation, has a differing distance profile within all three systems studied. Salt bridges in the metal binding region of the peptide are strongly altered; in particular, the Arg5-Asp7 salt bridge, which has an occurrence of 71% in the free peptide, is reduced to zero in the presence of both metals.
Collapse
Affiliation(s)
- Shaun T. Mutter
- School of Chemistry, Cardiff University, Park Place, Cardiff CF10 3AT, United Kingdom
| | - Matthew Turner
- School of Chemistry, Cardiff University, Park Place, Cardiff CF10 3AT, United Kingdom
| | - Robert J. Deeth
- Department of Chemistry, University of Warwick, Gibbet Hill, Coventry CV4 7AL, United Kingdom
| | - James A. Platts
- School of Chemistry, Cardiff University, Park Place, Cardiff CF10 3AT, United Kingdom
| |
Collapse
|
19
|
Vyas NA, Singh SB, Kumbhar AS, Ranade DS, Walke GR, Kulkarni PP, Jani V, Sonavane UB, Joshi RR, Rapole S. Acetylcholinesterase and Aβ Aggregation Inhibition by Heterometallic Ruthenium(II)-Platinum(II) Polypyridyl Complexes. Inorg Chem 2018; 57:7524-7535. [PMID: 29893118 DOI: 10.1021/acs.inorgchem.8b00091] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Two heteronuclear ruthenium(II)-platinum(II) complexes [Ru(bpy)2(BPIMBp)PtCl2]2+ (3) and [Ru(phen)2(BPIMBp)PtCl2]2+ (4), where bpy = 2,2'-bipyridine, phen = 1,10-phenanthroline, and BPIMBp = 1,4'-bis[(2-pyridin-2-yl)-1H-imidazol-1-ylmethyl]-1,1'-biphenyl, have been designed and synthesized from their mononuclear precursors [Ru(bpy)2(BPIMBp)]2+ (1) and [Ru(phen)2(BPIMBp)]2+ (2) as multitarget molecules for Alzheimer's disease (AD). The inclusion of the cis-PtCl2 moiety facilitates the covalent interaction of Ru(II) polypyridyl complexes with amyloid β (Aβ) peptide. These multifunctional complexes act as inhibitors of acetylcholinesterase (AChE), Aβ aggregation, and Cu-induced oxidative stress and protect neuronal cells against Aβ-toxicity. The study highlights the design of metal based anti-Alzheimer's disease (AD) systems.
Collapse
Affiliation(s)
- Nilima A Vyas
- Department of Chemistry , Savitribai Phule Pune University , Pune - 411007 , India
| | - Sushma B Singh
- Department of Chemistry , Savitribai Phule Pune University , Pune - 411007 , India
| | - Avinash S Kumbhar
- Department of Chemistry , Savitribai Phule Pune University , Pune - 411007 , India
| | - Dnyanesh S Ranade
- Bioprospecting Group, Agharkar Research Institute , Savitribai Phule Pune University , Pune - 411004 , India
| | - Gulshan R Walke
- Bioprospecting Group, Agharkar Research Institute , Savitribai Phule Pune University , Pune - 411004 , India
| | - Prasad P Kulkarni
- Bioprospecting Group, Agharkar Research Institute , Savitribai Phule Pune University , Pune - 411004 , India
| | - Vinod Jani
- Centre for Development of Advanced Computing (C-DAC) , Savitribai Phule Pune University , Pune - 411007 , India
| | - Uddhavesh B Sonavane
- Centre for Development of Advanced Computing (C-DAC) , Savitribai Phule Pune University , Pune - 411007 , India
| | - Rajendra R Joshi
- Centre for Development of Advanced Computing (C-DAC) , Savitribai Phule Pune University , Pune - 411007 , India
| | - Srikanth Rapole
- Proteomics Laboratory, National Centre for Cell Sciences , Savitribai Phule Pune University , Pune - 411007 , India
| |
Collapse
|
20
|
Wang X, Wang X, Guo Z. Metal-involved theranostics: An emerging strategy for fighting Alzheimer’s disease. Coord Chem Rev 2018. [DOI: 10.1016/j.ccr.2018.03.010] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
21
|
Ligand field molecular dynamics simulation of Pt(II)-phenanthroline binding to N-terminal fragment of amyloid-β peptide. PLoS One 2018; 13:e0193668. [PMID: 29509784 PMCID: PMC5839559 DOI: 10.1371/journal.pone.0193668] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2017] [Accepted: 02/15/2018] [Indexed: 12/15/2022] Open
Abstract
We report microsecond timescale molecular dynamics simulation of the complex formed between Pt(II)-phenanthroline and the 16 N-terminal residues of the Aβ peptide that is implicated in the onset of Alzheimer’s disease, along with equivalent simulations of the metal-free peptide. Simulations from a variety of starting points reach equilibrium within 100 ns, as judged by root mean square deviation and radius of gyration. Platinum-bound peptides deviate rather more from starting points, and adopt structures with larger radius of gyration, than their metal-free counterparts. Residues bound directly to Pt show smaller fluctuation, but others actually move more in the Pt-bound peptide. Hydrogen bonding within the peptide is disrupted by binding of Pt, whereas the presence of salt-bridges are enhanced.
Collapse
|
22
|
Turner M, Deeth RJ, Platts JA. Prediction of ligand effects in platinum-amyloid-β coordination. J Inorg Biochem 2017; 173:44-51. [PMID: 28494276 DOI: 10.1016/j.jinorgbio.2017.05.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2017] [Revised: 04/26/2017] [Accepted: 05/01/2017] [Indexed: 12/16/2022]
Abstract
Ligand field molecular mechanics (LFMM) and semi-empirical Parametric Model 7 (PM7) methods are applied to a series of six PtII-Ligand systems binding to the N-terminal domain of the amyloid-β (Aβ) peptide. Molecular dynamics using a combined LFMM/Assisted Model Building with Energy Refinement (AMBER) approach is used to explore the conformational freedom of the peptide fragment, and identifies favourable platinum binding modes and peptide conformations for each ligand investigated. Platinum coordination is found to depend on the nature of the ligand, providing evidence that binding mode may be controlled by suitable ligand design. Boltzmann populations at 310K indicate that each Pt-Aβ complex has a small number of thermodynamically accessible states. Ramachandran maps are constructed for the sampled Pt-Aβ conformations and secondary structural analysis of the obtained complex structures is performed and contrasted with the free peptide; coordination of these platinum complexes disrupts existing secondary structure in the Aβ peptide and promotes formation of ligand-specific turn-type secondary structure.
Collapse
Affiliation(s)
- Matthew Turner
- School of Chemistry, Cardiff University, Park Place, Cardiff CF10 3AT, United Kingdom
| | - Robert J Deeth
- Department of Chemistry, University of Warwick, Gibbet Hill, Coventry CV4 7AL, United Kingdom
| | - James A Platts
- School of Chemistry, Cardiff University, Park Place, Cardiff CF10 3AT, United Kingdom.
| |
Collapse
|
23
|
Brinet D, Gaie-Levrel F, Delatour V, Kaffy J, Ongeri S, Taverna M. In vitro monitoring of amyloid β-peptide oligomerization by Electrospray differential mobility analysis: An alternative tool to evaluate Alzheimer's disease drug candidates. Talanta 2017; 165:84-91. [DOI: 10.1016/j.talanta.2016.12.011] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2016] [Revised: 12/04/2016] [Accepted: 12/06/2016] [Indexed: 11/27/2022]
|
24
|
Banik D, Kundu S, Banerjee P, Dutta R, Sarkar N. Investigation of Fibril Forming Mechanisms of l-Phenylalanine and l-Tyrosine: Microscopic Insight toward Phenylketonuria and Tyrosinemia Type II. J Phys Chem B 2017; 121:1533-1543. [DOI: 10.1021/acs.jpcb.6b12220] [Citation(s) in RCA: 38] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Debasis Banik
- Department of Chemistry, Indian Institute of Technology, Kharagpur 721302, WB, India
| | - Sangita Kundu
- Department of Chemistry, Indian Institute of Technology, Kharagpur 721302, WB, India
| | - Pavel Banerjee
- Department of Chemistry, Indian Institute of Technology, Kharagpur 721302, WB, India
| | - Rupam Dutta
- Department of Chemistry, Indian Institute of Technology, Kharagpur 721302, WB, India
| | - Nilmoni Sarkar
- Department of Chemistry, Indian Institute of Technology, Kharagpur 721302, WB, India
| |
Collapse
|
25
|
Novato WT, Stroppa PHF, Da Silva AD, Botezine NP, Machado FC, Costa LAS, Dos Santos HF. Reaction between the Pt(II)-complexes and the amino acids of the β-amyloid peptide. Chem Phys Lett 2017. [DOI: 10.1016/j.cplett.2016.11.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
26
|
Solomatina AI, Chelushkin PS, Krupenya DV, Podkorytov IS, Artamonova TO, Sizov VV, Melnikov AS, Gurzhiy VV, Koshel EI, Shcheslavskiy VI, Tunik SP. Coordination to Imidazole Ring Switches on Phosphorescence of Platinum Cyclometalated Complexes: The Route to Selective Labeling of Peptides and Proteins via Histidine Residues. Bioconjug Chem 2016; 28:426-437. [DOI: 10.1021/acs.bioconjchem.6b00598] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- Anastasia I. Solomatina
- Saint Petersburg State University, Institute of
Chemistry, Universitetskii
prospect. 26, 198504 Saint Petersburg, Russia
| | - Pavel S. Chelushkin
- Saint Petersburg State University, Institute of
Chemistry, Universitetskii
prospect. 26, 198504 Saint Petersburg, Russia
- Institute
of Macromolecular Compounds, Russian Academy of Sciences, Bolshoi
prospect, Vasilievskii Island, 31, 199004 Saint Petersburg, Russia
| | - Dmitrii V. Krupenya
- Saint Petersburg State University, Institute of
Chemistry, Universitetskii
prospect. 26, 198504 Saint Petersburg, Russia
| | - Ivan S. Podkorytov
- Saint Petersburg State University, Biomolecular
NMR Laboratory, Botanicheskaya
Str., 17, 198504 Saint Petersburg, Russia
| | - Tatiana O. Artamonova
- Research
Center of Nanobiotechnologies, Peter the Great Saint Petersburg Polytechnic University, Polytechnicheskaya, 29, 195251 Saint Petersburg, Russia
| | - Vladimir V. Sizov
- Saint Petersburg State University, Institute of
Chemistry, Universitetskii
prospect. 26, 198504 Saint Petersburg, Russia
| | - Alexei S. Melnikov
- Saint Petersburg State University, Department
of Physics, Ulianovskaya
Str., 3, 198504 Saint Petersburg, Russia
- Research
Center of Nanobiotechnologies, Peter the Great Saint Petersburg Polytechnic University, Polytechnicheskaya, 29, 195251 Saint Petersburg, Russia
| | - Vladislav V. Gurzhiy
- Saint Petersburg State University, Institute of Earth Sciences and Biology Department, University embankment. 7/9, 199034 Saint Petersburg, Russia
| | - Elena I. Koshel
- Saint Petersburg State University, Institute of Earth Sciences and Biology Department, University embankment. 7/9, 199034 Saint Petersburg, Russia
| | | | - Sergey P. Tunik
- Saint Petersburg State University, Institute of
Chemistry, Universitetskii
prospect. 26, 198504 Saint Petersburg, Russia
| |
Collapse
|
27
|
Silva DES, Cali MP, Pazin WM, Carlos-Lima E, Salles Trevisan MT, Venâncio T, Arcisio-Miranda M, Ito AS, Carlos RM. Luminescent Ru(II) Phenanthroline Complexes as a Probe for Real-Time Imaging of Aβ Self-Aggregation and Therapeutic Applications in Alzheimer’s Disease. J Med Chem 2016; 59:9215-9227. [DOI: 10.1021/acs.jmedchem.6b01130] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- Debora E. S. Silva
- Departamento
de Química, Universidade Federal de São Carlos, São
Carlos, São Paulo 13565-905, Brazil
| | - Mariana P. Cali
- Departamento
de Química, Universidade Federal de São Carlos, São
Carlos, São Paulo 13565-905, Brazil
| | - Wallance M. Pazin
- Departamento de
Física, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, USP, Ribeirão Preto, São Paulo 14040-901, Brazil
| | - Estevão Carlos-Lima
- Departamento
de Biofísica, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, São Paulo 04023-062, Brazil
| | - Maria Teresa Salles Trevisan
- Departamento
de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Ceará Fortaleza, 60451-970, Brazil
| | - Tiago Venâncio
- Departamento
de Química, Universidade Federal de São Carlos, São
Carlos, São Paulo 13565-905, Brazil
| | - Manoel Arcisio-Miranda
- Departamento
de Biofísica, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, São Paulo 04023-062, Brazil
| | - Amando S. Ito
- Departamento de
Física, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, USP, Ribeirão Preto, São Paulo 14040-901, Brazil
| | - Rose M. Carlos
- Departamento
de Química, Universidade Federal de São Carlos, São
Carlos, São Paulo 13565-905, Brazil
| |
Collapse
|
28
|
Vyas NA, Ramteke SN, Kumbhar AS, Kulkarni PP, Jani V, Sonawane UB, Joshi RR, Joshi B, Erxleben A. Ruthenium(II) polypyridyl complexes with hydrophobic ancillary ligand as Aβ aggregation inhibitors. Eur J Med Chem 2016; 121:793-802. [PMID: 27406812 DOI: 10.1016/j.ejmech.2016.06.038] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2015] [Revised: 06/15/2016] [Accepted: 06/20/2016] [Indexed: 11/28/2022]
Abstract
The synthesis, spectral and electrochemical characterization of the complexes of the type [Ru(NN)2(txbg)](2+) where NN is 2,2'-bipyridine (bpy) (1), 1,10-phenanthroline (phen) (2), dipyrido [3,2-d:2',3f] quinoxaline (dpq) (3), and dipyrido[3,2-a:2',3'-c]phenazine (dppz) (4) which incorporate the tetra-xylene bipyridine glycoluril (txbg) as the ancillary ligand are described in detail. Crystal structures of ligand txbg and complex 2 were solved by single crystal X-ray diffraction. Thioflavin T (ThT) fluorescence and Transmission Electron Microscopy (TEM) results indicated that at micromolar concentration all complexes exhibit significant potential of Aβ aggregation inhibition, while the ligand txbg displayed weak activity towards Aβ aggregation. Complex 1 showed relatively low inhibition (70%) while complexes 2-4 inhibited nearly 100% Aβ aggregation after 240 h of incubation. The similar potential of complexes 2-4 and absence of any trend in their activity with the planarity of polypyridyl ligands suggests there is no marked effect of planarity of coligands on their inhibitory potential. Further studies on acetylcholinesterase (AChE) inhibition indicated very weak activity of these complexes against AChE. Detailed interactions of Aβ with both ligand and complex 2 have been studied by molecular modeling. Complex 2 showed interactions involving all three polypyridyl ligands with hydrophobic region of Aβ. Furthermore, the toxicity of these complexes towards human neuroblastoma cells was evaluated by MTT assay and except complex 4, the complexes displayed very low toxicity.
Collapse
Affiliation(s)
- Nilima A Vyas
- Department of Chemistry, Savitribai Phule Pune University, Pune, 411007, India
| | | | - Avinash S Kumbhar
- Department of Chemistry, Savitribai Phule Pune University, Pune, 411007, India.
| | | | - Vinod Jani
- Bioinformatics Group, Centre for Development of Advanced Computing (C-DAC), Savitribai Phule Pune University, Pune, 411007, India
| | - Uddhavesh B Sonawane
- Bioinformatics Group, Centre for Development of Advanced Computing (C-DAC), Savitribai Phule Pune University, Pune, 411007, India
| | - Rajendra R Joshi
- Bioinformatics Group, Centre for Development of Advanced Computing (C-DAC), Savitribai Phule Pune University, Pune, 411007, India
| | - Bimba Joshi
- Bioprospecting, Agharkar Research Institute, Pune, 411004, India
| | - Andrea Erxleben
- School of Chemistry, National University of Ireland, Galway, Ireland
| |
Collapse
|
29
|
Turner M, Platts JA, Deeth RJ. Modeling of Platinum-Aryl Interaction with Amyloid-β Peptide. J Chem Theory Comput 2016; 12:1385-92. [PMID: 26756469 DOI: 10.1021/acs.jctc.5b01045] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Ligand field molecular mechanics (LFMM), density functional theory (DFT), and semiempirical PM7 methods are used to study the binding of two Pt(II)-L systems to an N-terminal fragment of the amyloid-β peptide, where L = 2,2-bipyridyl or 1,10-phenanthroline. Molecular dynamics simulations are used to explore the conformational freedom of the peptide using LFMM combined with AMBER molecular mechanics parameters. We establish a modeling protocol, allowing for identification and analysis of favorable platinum-binding modes and peptide conformations. Preferred binding modes are identified for each ligand investigated; metal coordination occurs via Nε in His residues for both ligands--His6ε-His13ε and His6ε-His14ε for the bipyridyl and phenanthroline ligands, respectively. The observed change in binding mode for the different ligands suggests that the binding mode of these platinum-based structures can be controlled by the choice of ligand. In the bipy systems, Boltzmann population at 310 K is dominated by a single conformer, while in the phenanthroline case, three conformations make significant contributions to the ensemble. The relative stability of these conformations is due to the inherent stability of binding platinum via Nε in addition to subtle H-bonding effects.
Collapse
Affiliation(s)
- Matthew Turner
- School of Chemistry, Cardiff University , Park Place, Cardiff CF10 3AT, U.K
| | - James A Platts
- School of Chemistry, Cardiff University , Park Place, Cardiff CF10 3AT, U.K
| | - Robert J Deeth
- Department of Chemistry, University of Warwick , Gibbet Hill, Coventry CV4 7AL, U.K
| |
Collapse
|
30
|
Lu L, Zhong HJ, Wang M, Ho SL, Li HW, Leung CH, Ma DL. Inhibition of Beta-Amyloid Fibrillation by Luminescent Iridium(III) Complex Probes. Sci Rep 2015; 5:14619. [PMID: 26419607 PMCID: PMC4588514 DOI: 10.1038/srep14619] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2015] [Accepted: 05/01/2015] [Indexed: 11/20/2022] Open
Abstract
We report herein the application of kinetically inert luminescent iridium(III) complexes as dual inhibitors and probes of beta-amyloid fibrillogenesis. These iridium(III) complexes inhibited Aβ1–40 peptide aggregation in vitro, and protected against Aβ-induced cytotoxicity in neuronal cells. Furthermore, the complexes differentiated between the aggregated and unaggregated forms of Aβ1–40 peptide on the basis of their emission response.
Collapse
Affiliation(s)
- Lihua Lu
- Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China
| | - Hai-Jing Zhong
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China
| | - Modi Wang
- Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China
| | - See-Lok Ho
- Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China
| | - Hung-Wing Li
- Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China
| | - Chung-Hang Leung
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China
| | - Dik-Lung Ma
- Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China
| |
Collapse
|
31
|
Walke GR, Rapole S, Kulkarni PP. Cisplatin inhibits the formation of a reactive intermediate during copper-catalyzed oxidation of amyloid β peptide. Inorg Chem 2014; 53:10003-5. [PMID: 25237806 DOI: 10.1021/ic5007764] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Cisplatin was studied for its effect on the copper-catalyzed oxidation of amyloid β (Aβ) peptide. The interaction of cisplatin with Aβ1-16 in the presence of Cu(II) was investigated using cyclic voltammetry and mass spectrometry. The positive shift in the E1/2 value of Aβ1-16-Cu(II) suggests that the interaction of cisplatin alters the copper-binding properties of Aβ1-16. The mass spectrometry data show complete inhibition of copper-catalyzed decarboxylation/deamination of the Asp1 residue of Aβ1-16, while there is a significant decrease in copper-catalyzed oxidation of Aβ1-16 in the presence of cisplatin. Overall, our results provide a novel mode by which cisplatin inhibits copper-catalyzed oxidation of Aβ. These findings may lead to the design of better platinum complexes to treat oxidative stress in Alzheimer's disease and other related neurological disorders.
Collapse
Affiliation(s)
- Gulshan R Walke
- Biometry and Nutrition Group, Agharkar Research Institute , Pune, India
| | | | | |
Collapse
|
32
|
Heffern MC, Velasco PT, Matosziuk LM, Coomes JL, Karras C, Ratner MA, Klein WB, Eckermann AL, Meade TJ. Modulation of amyloid-β aggregation by histidine-coordinating Cobalt(III) Schiff base complexes. Chembiochem 2014; 15:1584-9. [PMID: 24961930 PMCID: PMC4166533 DOI: 10.1002/cbic.201402201] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2014] [Indexed: 01/14/2023]
Abstract
Oligomers of the Aβ42 peptide are significant neurotoxins linked to Alzheimer's disease (AD). Histidine (His) residues present at the N terminus of Aβ42 are believed to influence toxicity by either serving as metal-ion binding sites (which promote oligomerization and oxidative damage) or facilitating synaptic binding. Transition metal complexes that bind to these residues and modulate Aβ toxicity have emerged as therapeutic candidates. Cobalt(III) Schiff base complexes (Co-sb) were evaluated for their ability to interact with Aβ peptides. HPLC-MS, NMR, fluorescence, and DFT studies demonstrated that Co-sb complexes could interact with the His residues in a truncated Aβ16 peptide representing the Aβ42 N terminus. Coordination of Co-sb complexes altered the structure of Aβ42 peptides and promoted the formation of large soluble oligomers. Interestingly, this structural perturbation of Aβ correlated to reduced synaptic binding to hippocampal neurons. These results demonstrate the promise of Co-sb complexes in anti-AD therapeutic approaches.
Collapse
Affiliation(s)
- Marie C. Heffern
- Departments of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering, and Radiology, Northwestern University, Evanston, IL 60208-3113, USA
| | - Pauline T. Velasco
- Department of Neurobiology, Northwestern University, Evanston, IL 60208-3113, USA
| | - Lauren M. Matosziuk
- Departments of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering, and Radiology, Northwestern University, Evanston, IL 60208-3113, USA
| | - Joseph L. Coomes
- Departments of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering, and Radiology, Northwestern University, Evanston, IL 60208-3113, USA
| | - Constantine Karras
- Departments of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering, and Radiology, Northwestern University, Evanston, IL 60208-3113, USA
| | - Mark A. Ratner
- Department of Chemistry, Northwestern University, Evanston, IL 60208-3113, USA
| | - William B. Klein
- Department of Neurobiology, Northwestern University, Evanston, IL 60208-3113, USA
| | - Amanda L. Eckermann
- Departments of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering, and Radiology, Northwestern University, Evanston, IL 60208-3113, USA
| | - Thomas J. Meade
- Departments of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering, and Radiology, Northwestern University, Evanston, IL 60208-3113, USA
| |
Collapse
|
33
|
Hayne DJ, Lim S, Donnelly PS. Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease. Chem Soc Rev 2014; 43:6701-15. [PMID: 24671229 DOI: 10.1039/c4cs00026a] [Citation(s) in RCA: 124] [Impact Index Per Article: 12.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Alzheimer's disease is the most common form of age-related neurodegenerative dementia. The disease is characterised by the presence of plaques in the cerebral cortex. The major constituent of these plaques is aggregated amyloid-β peptide. This review focuses on the molecular aspects of metal complexes designed to bind to amyloid-β. The development of radioactive metal-based complexes of copper and technetium designed as diagnostic imaging agents to detect amyloid burden in the brain is discussed. Separate sections of the review discuss the use of luminescent metal complexes to act as non-conventional probes of amyloid formation and recent research into the use of metal complexes as inhibitors of amyloid formation and toxicity.
Collapse
Affiliation(s)
- David J Hayne
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, 3010, Australia.
| | | | | |
Collapse
|
34
|
Abstract
Platinum-complexes represent some of the most successful groups of clinically used anticancer drugs. Their mechanism of action relies on the formation of stable DNA adducts occurring at the nitrogen in position 7 of guanine (N7) and involving one or two spatially close residues. The formation of stable DNA adducts is recognized as a DNA damaging event and, ultimately, drives cells to death. Nevertheless, nucleobases are not the only reliable targets of these drugs and other biomolecules can be involved. Among them large interest has been devoted to proteins since they contain several potential reactive sites for platinum (His, Met, and Cys) and, in particular, because the reaction of the metal with sulfur containing groups is a kinetically favored process. As a result, the occurrence of protein adducts and DNA-protein cross-links must be further taken into account in order to fully define cisplatin mechanism of action. Herein, we will summarize the most recent experimental evidence collected so far on protein-cisplatin adduct formation to better dissect its correlation with the drug pharmacological profile. Indeed, in addition to modulation of drug bioavailability and toxicity, the potential role of proteins as reaction intermediates or reservoir systems in platinum drugs can be envisaged. Additionally, the effects of Pt-coordinating groups on the chemical reactivity of the metal complexes will be reviewed. From all these outcomes a general model for Pt-based drugs mechanism of action can be drawn which is more articulate than the one currently supported. It claims proteins as reactive intermediates for DNA platination and it defines them as relevant to fully describe the clinical potential of this class of anticancer drugs.
Collapse
Affiliation(s)
- O Pinato
- Department of Pharmaceutical and Pharmacological Science, v. Marzolo 5, 35131 Padova, Italy.
| | | | | |
Collapse
|
35
|
Hureau C, Faller P. Platinoid complexes to target monomeric disordered peptides: a forthcoming solution against amyloid diseases? Dalton Trans 2014; 43:4233-7. [DOI: 10.1039/c3dt52954a] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|